Avila / Galili | ¿¿Gal and Anti¿Gal | Buch | 978-1-4613-7160-1 | sack.de

Buch, Englisch, Band 32, 394 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 628 g

Reihe: Subcellular Biochemistry

Avila / Galili

¿¿Gal and Anti¿Gal

¿1,3¿Galactosyltransferase, ¿¿Gal Epitopes, and the Natural Anti¿Gal Antibody Subcellular Biochemistry

Buch, Englisch, Band 32, 394 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 628 g

Reihe: Subcellular Biochemistry

ISBN: 978-1-4613-7160-1
Verlag: Springer US


It has been 15 years since the first report on the isolation of anti-Gal from human serum and the demonstration that this antibody is the most prevalent antibody in humans (Galili et al., ]. Exp. Med. 160: 1519, 1984). Subsequent interdisciplinary studies in immunology, carbohydrate biochemistry, molecular biology, and evo­ lution demonstrated the highly restricted specificity of anti-Gal for the carbohy­ drate epitope Gal al-3Galpl-4GIcNAc-R, (termed here the a-gal epitope), the unprecedented evolutionary pattern of distribution of a-gal and anti-Gal in mam­ mals, and explained the evolution of this antigen and antibody by analysis of the a 1 ,3galactosyltransferase gene, the gene that encodes the enzyme that synthesizes the a-gal epitope. These studies have suggested that a major selection process that occurred in the course of evolution of ancestral Old World primates resulted in the inactivation of the a1 ,3galactosyltransferase gene and the subsequent appearance of anti-Gal in these primates. Other studies in immunoparasitology have demon­ strated the possible physiologic significance of anti-Gal in protection against cer­ tain parasitic infections. Major scientific attention was focused on a-gal and anti-Gal with the real­ ization in the early nineties that the interaction between this antigen and antibody is the major obstacle to xenotransplantation. The success of immunosuppressive drugs, in the last two decades of the 20th century, in preventing allograft rejection, has raised hopes for cure in many patients in need of organ transplant. Because of limited supply of allografts, only 20% of patients receive the needed organ.
Avila / Galili ¿¿Gal and Anti¿Gal jetzt bestellen!

Zielgruppe


Research

Weitere Infos & Material


1 Evolution of ?l,3Galactosyltransferase and of the ?-Gal Epitope.- 2 The ?1,3-Galactosyltransferase Gene.- 3 Structure Function Studies of a New World Monkey ?1,3Galactosyltransferase: Analysis of Alternative Splicing and Expression in Baculovirus System.- 4 The Natural Anti-Gal Antibody.- 5 ?-Gal Epitopes in Animal Tissue Glycoproteins and Glycolipids.- 6 The Griffonia simplicifolia I — B4 Isolectin: A Probe for ?-D- Galactosyl End Groups.- 7 ?-Gal Epitopes on Viral Glycoproteins.- 8 ?-Galactosyl-Bearing Epitopes as Potent Immunogens in Chagas’ Disease and Leishmaniasis.- 9 Enterotoxin A of Clostridium difficile and ?-Gal Epitopes.- 10 Anti-Gal, ?-Gal Epitopes, and Xenotransplantation.- 11 Generation of ?1,3Galactosyltransferase Deficient Mice.- 12 Anti-Xenograft Immune Responses in ?1,3-Galactosyltransferase Knock-Out Mice.- 13 Modulation of ?Gal Epitope Expression on Porcine Cells.- 14 Graves’ Disease as a Model for Anti-Gal Involvement in Autoimmune Diseases.- 15 Enhancement of Autologous Tumor Vaccine Immunogenicity by Anti-Gal.


Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.